0001209191-23-004300.txt : 20230120
0001209191-23-004300.hdr.sgml : 20230120
20230120170855
ACCESSION NUMBER: 0001209191-23-004300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221108
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Andrew Kenneth William
CENTRAL INDEX KEY: 0001304113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 23541759
MAIL ADDRESS:
STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC.
STREET 2: 41 UNIVERSITY DRIVE
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-08
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001304113
Powell Andrew Kenneth William
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE
PA
19087
1
0
0
0
Common Stock
2022-11-08
5
G
0
E
4000
0.00
D
9856
D
/s/ Mark Ballantyne, Attorney-in-Fact
2023-01-20